Galena Biopharma Inc (NASDAQ:GALE) has announced it will have two post presentations at next week’s San Antonio Breast Cancer Symposium: “VADIS Trial: Phase …
Next Wednesday, December 7th, Starbucks Corporation (NASDAQ:SBUX) intends to host its biennial Analyst Meeting that is set to take place in New York …
Merrill Lynch analyst Justin Post is all the more upbeat on Amazon.com, Inc.
In a research report released Friday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Galena Biopharma Inc (NASDAQ:GALE), while adjusting …
Let’s talk about F.A.
The biotech-verse is in full upheaval mode as Heat Biologics Inc (NASDAQ:HTBX) shares nosedive following disheartening Phase II results in bladder cancer and …
Rumors are abuzz that Amazon.com, Inc.
bluebird bio Inc (NASDAQ:BLUE) shares are surging 25% after releasing interim results from the firm’s Phase 1 trial of its anti-BCMA CAR T …
Cowen analyst Ritu Baral is out with a research report on shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) after conducting separate surveys of 25 …
Top analyst Youssef Squali at Cantor is detailing sunny, blue skies ahead for two of the tech industry’s leading players, Facebook Inc (NASDAQ:FB) …
